Polymorphic Enhancer near GREM1 Influences Bowel Cancer Risk through Differential CDX2 and TCF7L2 Binding
Lewis A., Freeman-Mills L., de la Calle-Mustienes E., Giráldez-Pérez RM., Davis H., Jaeger E., Becker M., Hubner NC., Nguyen LN., Zeron-Medina J., Bond G., Stunnenberg HG., Carvajal JJ., Gomez-Skarmeta JL., Leedham S., Tomlinson I.